Scroll To Top
Search by Speciality


Palais du Pharo * | Marseille, FRANCE
From 230 to 850 EUR
Event Preview
This event
is Finished
Specialty: , Medical Oncology, Nephrology, Urology
Dates: From Jun, 12, 2013 to Jun, 14, 2013
Location: Marseille, FRANCE
Type: Congress
Registration Cost: From 230 to 850 EUR
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Marseille, France.
General Info
Event Venue:

Palais du Pharo *

Marseille, FRANCE Visit the Venue to read more
Transportation Guide:

How to get there

Palais du Pharo

58 Boulevard Charles Livon
13007 Marseille

By car

By train

Take the train (TGV) to the international railway station Marseille St. Charles. The congress venue is at 3 km from here.

By plane

The international Airport Marseille Provence is located 25 km outside the centre of Marseille, in Marignane.
At the Airport, there are several trains and shuttle buses to railway station Marseille St. Charles.

Event Overview
Welcome message:

This second Global Congress on Prostate Cancer will continue to focus on topics which are actual and controversial, and which are of interest to all specialties dealing with prostate cancer. Unfortunately many of the practical questions are not addressed at congresses today.  In order to do so, we think we need to go in depth and beyond classical congress formats as well as geographical and disciplinary boundaries.

Therefore we will evaluate the areas of uncertainty before the congress using the uniquely built interactive decision algorithms “Mirrors of Medicine” (MiMe) so that at the Global Congress, we can focus our interactions and discussions when reviewing research findings and key decision making. We would like to invite you before, during and after the congress to share and discuss your vision on how to translate the scientific clinical evidence into best daily practice.


Main programme

  • Walter Artibani
    University Hospital of Verona
    Verona, Italy
  • Lodovico Balducci
    University of South Florida College of Medicine and Moffitt Cancer centre
    Tampa, United States
  • Jelle Barentsz
    University Medical Centre Radboud
    Nijmegen, Netherlands
  • Dominik Berthold
    University Hospital of Lausanne
    Lausanne, Switzerland
  • Michel Bolla
    University Hospital of Grenoble
    Grenoble, France
  • Alberto Bossi
    Gustave Roussy Institute
    Villejuif, France
  • Alberto Briganti
    San Raffaele Scientific Institute, Vita-Salute San Raffaele University
    Milan, Italy
  • François Cornud
    Medical Imaging centre Tourville
    Paris, France
  • Anthony J. Costello
    Royal Melbourne Hospital
    Melbourne, Australia
    Juanita Crook
    British Columbia Cancer Agency
    Vancouver, Canada
  • Gert De Meerleer
    University of Ghent
    Ghent, Belgium
  • Maria De Santis
    Kaiser Franz Josef Hospital - SMZ South
    Vienna, Austria
  • David Dearnaley
    Royal Marsden Hospital
    London, United Kingdom
  • Nandita deSouza
    Royal Marsden Hospital
    London, United Kingdom
  • Jean-Pierre Droz
    Léon Bérard cancer centre
    Lyon, France
  • James A. Eastham
    Memorial Sloan-Kettering Cancer centre
    New York, United States
  • Eleni Efstathiou
    University of Athens
    Athens, Greece
  • Mark Emberton
    Centre for Urological Care
    London, United Kingdom
  • Karim Fizazi
    Gustave Roussy Institute
    Villejuif, France
  • Alexander Govorov
    Moscow State Medical Stomatological University
    Moscow, Russia
    Gwenaelle Gravis
    Paoli-Calmettes Institute Cancer Centre
    Marseille, France
  • Henrik Grönberg
    Karolinska Institute
    Stockholm, Sweden
  • Ferran Guedea
    Catalan Institute of Oncology
    Barcelona, Spain
  • Bertrand Guilloneau
    Hospital of Diaconesses
    Paris, France
  • Peter Hoskin
    Mount Vernon Hospital
    Northwood, United Kingdom
  • Steven Joniau
    University Hospitals Leuven
    Leuven, Belgium
  • R. Jeffrey Karnes
    Mayo Clinic
    Rochester, United States
  • Laurence Klotz
    Sunnybrook Health Sciences Centre
    Toronto, Canada
  • Deborah A. Kuban
    MD Anderson Cancer Centre Orlando
    Houston, United States
    Christophe Massard
    Gustave Roussy Institute
    Villejuif, France
  • Raymond Miralbell
    University Hospital
    Geneva, Switzerland
  • Francesco Montorsi
    Vita-Salute San Raffaele University
    Milan, Italy
  • Nicolas Mottet
    University Hospital
    St. Etienne, France
  • Alex Mottrie
    OLV Clinic
    Aalst, Belgium
  • Joel Nelson
    University of Pittsburgh School of Medicine
    Pittsburgh, United States
    Thomas Powles
    St. Bartholomew's Hospital and the Royal London Hospital
    London, United Kingdom
  • Mack Roach III
    University of California
    San Francisco, United States
  • Olivier Rouvière
    University Hospital of Lyon
    Lyon, Belgium
  • Martin Spahn
    University Hospital of Urology
    Bern, Switzerland
  • Andrew J. Stephenson
    Cleveland Clinic
    Cleveland, United States
  • Ash Tewari
    The New York Presbyterian Hospital-Weill Cornell Medical centre
    New York, United States
    Karim Touijer
    Memorial Sloan-Kettering Cancer centre
    New York, United States
  • Riccardo Valdagni
    IRCCS National Cancer Institute
    Milan, Italy
  • Uulke Van Der Heide
    the Netherlands Cancer Institute (NKI-AVL)
    Amsterdam, Netherlands
  • Jeroen van Moorselaar
    VUmc Cancer centre Amsterdam
    Amsterdam, Netherlands
  • Inge van Oort
    University Medical Centre Radboud
    Nijmegen, Netherlands
  • Geert Villeirs
    Ghent University Hospital
    Ghent, Belgium
  • Arnauld Villers
    Hospital Claude Huriez, Regional University Hospital centre of Lille
    Lille, France
  • Jochen Walz
    Paoli-Calmettes Institute Cancer Centre
    Marseille, France
    Anders Widmark
    Umeå University Hospital
    Umeå, Sweden
  • Thomas Wiegel
    University Hospital Ulm
    Ulm, Germany
  • Peter Wiklund
    Karolinska Hospital
    Stockholm, Sweden
  • Michael J. Zelefsky
    Memorial Sloan-Kettering Cancer centre
    New York, United States
Registration Not yet available Register Now

Please note that availability of the rooms in the hotel cannot be guaranteed. Many events will take place in Marseille in the context of European Capital of Culture 2013, so the number of available rooms is limited. Be sure to make your hotel reservation in time!

You are responsible for making your own hotel arrangements. Congress registration fees do not include room reservation.

Further Details:

Hotel cancellation policies

Participants should take note of all reservation conditions, payment, and cancellation policies directly with the hotel (s)he booked with.
The Congress Organisers shall not be responsible for any accommodation expenses incurred - directly or indirectly.

Scientific Content Up to Date
Submission Info

You can submit your abstract on prostate cancer before 15 April 2013. All the abstracts will be reviewed by several members of the Organising and Scientific Committee. Authors of the accepted abstracts can present this as a poster.

Out of the submitted abstracts, three are selected as winning posters. The authors of the three winning posters are invited to give an 8-minute presentation in the main auditorium on Saturday afternoon to present their work. They will also receive an award.

Editorial Guidelines for Presented Content:

Poster format

Submitters of an abstract accepted for a poster should bring their poster in A0 format (portrait or landscape) to the congress. All posters should be in English. The posters will be displayed in the poster area. 

Sponsors Exhibitors
Organising Agency

Contact: , Congress Management , e-HIMS

Phone: 011-32-3-800-0654

Official Event Webpage
Event map
Revelant Events